Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic Status
JAMA Oncol
.
2021 Jun 1;7(6):939-940.
doi: 10.1001/jamaoncol.2021.0376.
Authors
Arnaud Bayle
1
2
,
Fabrice Barlesi
3
4
,
Christophe Massard
1
2
Affiliations
1
Drug Development Department (DITEP), Gustave Roussy-Cancer Campus, Villejuif, France.
2
Université Paris Sud, Université Paris, Saclay, France.
3
Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif, France.
4
Aix-Marseille University, CNRS, INSERM, CRCM, Marseille, France.
PMID:
33792621
DOI:
10.1001/jamaoncol.2021.0376
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Neoplasms* / therapy
Patient Participation*